Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study

Cancer Epidemiology

Volumn 41, Issue , 2016, Pages 129-131

  Mostaghimi, Arash ^a   Qureshi, Sarah ^a   Joyce, Cara ^b   Guo, Ye ^a   Huang, Kathie P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Alopecia areata; Autoimmunity; Basal cell carcinoma; Epidemiology; Melanocytes; Melanoma; Non melanoma skin cancer; Squamous cell carcinoma; Vitiligo

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON;

ADULT; ALOPECIA AREATA; ARTICLE; AUTOIMMUNITY; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; MULTICENTER STUDY; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; TERTIARY CARE CENTER; UNITED STATES; VITILIGO; INCIDENCE; MIDDLE AGED; RISK; SKIN NEOPLASMS;

ADULT; ALOPECIA AREATA; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; SKIN NEOPLASMS;

EID: 84960954217     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2016.02.009     Document Type: Article

References (14)

1. Todes-Taylor N., Turner R., Wood G.S., Strattes P.T., Morhenn V.B. T cell subpopulations in alopecia areata. J. Am. Acad. Dermatol. 1984, 11:216-223.
2. Hordinsky M., Ericson M. Autoimmunity: alopecia areata. J. Invest. Dermatol. Symp. Proc. 2004, 9:73-78.
3. van den Boorn J.G., Konijnenberg D., Dellemijn T.A., et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J. Invest. Dermatol. 2009, 129:2220-2232.
4. Teulings H.E., Overkamp M., Ceylan E., Nieuweboer-Krobotova L., Bos J.D., Nijsten T., et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br. J. Dermatol. 2013, 168:162-171.
5. 2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J. 2009, 23:3790-3807.
6. Gilhar A., Kam Y., Assy B., Kalish R.S. Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J. Invest. Dermatol. 2005, 124:288-289.
7. Harris J.E., Harris T.H., Weninger W., Wherry E.J., Hunter C.A., Turka L.A. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J. Invest. Dermatol. 2012, 132:1869-1876.
8. Tobin D.J., Fenton D.A., Kendall M.D. Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J. Invest. Dermatol. 1990, 94:803-807.
9. Huang K.P., Mullangi S., Guo Y., Qureshi A.A. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013, 149(7):789-794.
10. Garrido Colmenero C., Martín Castro A., Valenzuela Salas I., Martínez García E., Blasco Morente G., Tercedor Sánchez J. Squamous cell carcinoma in lichen planopilaris. J. Dermatol. Case Rep. 2013, 7(3):84-87.
11. Alsanafi S., Werth V.P. Squamous cell carcinomas arising in discoid lupus erythematosus scars: unusual occurrence in an African-American and in a sun-protected area. J. Clin. Rheumatol. 2011, 17:35-36.
12. Attia P., Phan G.Q., Maker A.V., et al. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J. Clin. Oncol. 2005, 23:6043-6053.
13. Lacouture M.E., Wolchok J.D., Yosipovitch G., et al. Ipilimumab in patients with cancer and the management of dermatologic adverse events. J. Am. Acad. Dermatol. 2014, 71:161-169.
14. Teulings H.E., Limpens J., Jansen S.N., et al. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. J. Clin. Oncol. 2015, 33(7):773-781.